カテゴリ： MarketLine, フランス, 企業調査

Pernod Ricard SA：企業の戦略・SWOT・財務分析

◆英語タイトル：Pernod Ricard SA - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4547
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：50
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：フランス
◆産業分野：Consumer Packaged Goods
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Pernod Ricard SA – Strategy, SWOT and Corporate Finance Report
Summary

Pernod Ricard SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Pernod Ricard SA (Pernod Ricard or ‘the company’) is a global distiller that produces spirits, wines, whisky, scotch, vodka, gin and other non-alcoholic beverages. The company offers a wide range of spirits under various global and local strategic brands. Its premium international brands have strong global reach and come with premium prices. These include, Beefeater, Chivas Regal, Absolut Vodka, Jameson, Perrier-Jouet, Malibu, Ricard, Ballantine’s, MUMM, Martell and others. The company’s local brands have presence across the world and come with nominal prices. Its major local brands include 100 Pipers, Imperial, Passport Scotch, Clan Campbell, Seagram’s, Ararat, Royal Stag, Blenders Pride, and others. The company has presence across the Americas, Europe, the Middle East and Africa, and Asia. It is headquartered in Paris, France.

Scope

- Detailed information on Pernod Ricard SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Pernod Ricard SA in the form of a SWOT analysis
- An in-depth view of the business model of Pernod Ricard SA including a breakdown and examination of key business segments
- Intelligence on Pernod Ricard SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Pernod Ricard SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Pernod Ricard SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Pernod Ricard SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Pernod Ricard SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Pernod Ricard SA: Company Overview
Pernod Ricard SA: Overview and Key Facts
Pernod Ricard SA: Overview
Pernod Ricard SA: Key Facts
Pernod Ricard SA: Key Employees
Pernod Ricard SA: Key Employee Biographies
Pernod Ricard SA: Major Products and Services
Pernod Ricard SA: Company History
Pernod Ricard SA: Locations and Subsidiaries
Pernod Ricard SA: Key Competitors
Pernod Ricard SA: Company Analysis
Pernod Ricard SA: Business Description
Pernod Ricard SA: SWOT Analysis
Pernod Ricard SA: SWOT Overview
Pernod Ricard SA: Strengths
Pernod Ricard SA: Weaknesses
Pernod Ricard SA: Opportunities
Pernod Ricard SA: Threats
Pernod Ricard SA: Corporate Financial Deals Activity
Pernod Ricard SA: Financial Deals Overview
Pernod Ricard SA: Targets and Partners
Pernod Ricard SA: Top Deals 2016 – 2020YTD*
Pernod Ricard SA: Advisors
Pernod Ricard SA: Top Legal Advisors
Pernod Ricard SA: Top Financial Advisors
Pernod Ricard SA: Mergers and Acquisitions
Pernod Ricard SA: Partnership
Pernod Ricard SA: Divestments
Pernod Ricard SA: Private Equity and Ownership
Pernod Ricard SA: Recent Developments
Pernod Ricard SA: News and Events Summary
Pernod Ricard SA: Business Expansion
Pernod Ricard SA: Corporate Governance
Pernod Ricard SA: Corporate Social Responsibility
Pernod Ricard SA: Financial Deals
Pernod Ricard SA: Financial Performance
Pernod Ricard SA: Red Flags/DistressSignals
Pernod Ricard SA: Research & Development
Pernod Ricard SA: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Pernod Ricard SA: Key Facts
Table 2: Pernod Ricard SA: Key Employees
Table 3: Pernod Ricard SA: Company History
Table 4: Pernod Ricard SA: Locations and Subsidiaries
Table 5: Pernod Ricard SA: Key Competitors
Table 6: Pernod Ricard SA: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Pernod Ricard SA: M&A Activity by Geography (TTM*)
Table 8: Pernod Ricard SA: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Pernod Ricard SA: M&A Average Deal Size - Value (US$m)
Table 10: Pernod Ricard SA: Targets and Partners
Table 11: Pernod Ricard SA: Top Deals 2016 - 2020YTD*
Table 12: Pernod Ricard SA: Legal Advisor Ranking by Value (US$m)
Table 13: Pernod Ricard SA: Financial Advisor Ranking by Value (US$m)
Table 14: Pernod Ricard SA: M&A Volume and Value Trend (2016 - YTD*2020)
Table 15: Pernod Ricard SA: M&A Activity by Geography (2016 - YTD*2020)
Table 16: Pernod Ricard SA: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 17: Pernod Ricard SA: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 18: Pernod Ricard SA: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 19: Pernod Ricard SA: Divestments by Geography (2016 - YTD*2020)
Table 20: Pernod Ricard SA: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 21: Pernod Ricard SA: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 22: Pernod Ricard SA: News and Events Summary
Table 23: Pernod Ricard SA: Business Expansion
Table 24: Pernod Ricard SA: Corporate Governance
Table 25: Pernod Ricard SA: Corporate Social Responsibility
Table 26: Pernod Ricard SA: Financial Deals
Table 27: Pernod Ricard SA: Financial Performance
Table 28: Pernod Ricard SA: Red Flags/DistressSignals
Table 29: Pernod Ricard SA: Research & Development
Table 30: Pernod Ricard SA: Strategy and Operations

★海外企業調査レポート[Pernod Ricard SA：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Sichuan Kelun Pharmaceutical Co Ltd (002422)-製薬・医療分野：企業M&A・提携分析
    Summary Sichuan Kelun Pharmaceutical Co Ltd (Kelun) is a pharmaceutical company that manufactures and distributes IV Solutions. The company’s products include mannitol injection, glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer’s injection, lactated ringer’ …
  • Amarin Corp Plc (AMRN)：企業の財務・戦略的SWOT分析
    Amarin Corp Plc (AMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Dicerna Pharmaceuticals Inc (DRNA)：企業の財務・戦略的SWOT分析
    Summary Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that discovers and develops therapeutics for the treatment of rare inherited diseases and cancers. The company’s lead product DCR-PHXC is used for the treatment of primary hyperoxaluria (PH). It offers RNAi technology platf …
  • Gilbane Inc：企業の戦略・SWOT・財務分析
    Gilbane Inc - Strategy, SWOT and Corporate Finance Report Summary Gilbane Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Dova Pharmaceuticals Inc (DOVA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Dova Pharmaceuticals Inc (Dova), formerly PBM AKX Holdings LLC, is a clinical-stage pharmaceutical company that acquires, develops and commercializes therapies for the treatment of orphan diseases. The company’s lead candidate, Avatrombopag (DOPTELET), a novel, oral thrombopoietin receptor a …
  • Alabama Municipal Electric Authority：企業の戦略的SWOT分析
    Alabama Municipal Electric Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Sanquin Blood Supply Foundation-製薬・医療分野：企業M&A・提携分析
    Summary Sanquin Blood Supply Foundation (Sanquin) is a blood bank that supplies blood and promotes transfusion medicine. The organization offers plasma and blood products. Its services comprise diagnostic, consulting, reagents, DNA paternity testing, pharmaceutical, immuno monitoring services, biolo …
  • Netmedia S.A.：企業の戦略・SWOT・財務分析
    Netmedia S.A. - Strategy, SWOT and Corporate Finance Report Summary Netmedia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Avista Corporation：企業の戦略・SWOT・財務分析
    Avista Corporation - Strategy, SWOT and Corporate Finance Report Summary Avista Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • MI Bioresearch Inc-医療機器分野：企業M&A・提携分析
    Summary MI Bioresearch Inc (MI), formerly Molecular Imaging Inc is a research institute that offers pharmacology research services. The institute offers services such as oncology pharmacology, immuno oncology, in vitro services, imaging and radiation. Its oncology pharmacology include subcutaneous m …
  • Milo Biotechnology LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary Milo Biotechnology LLC (Milo) is a biotechnology company that develops novel therapies based on follistatin, a protein that increases muscle mass and strength. The company’s pipeline product includes AAV1 (based on adeno-associated virus), which is a gene therapy for the one time treatment o …
  • Ampcontrol Pty Ltd：企業の戦略・SWOT・財務情報
    Ampcontrol Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Ampcontrol Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Williams-Sonoma, Inc.：企業の戦略・SWOT・財務情報
    Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report Summary Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • DePuy Synthes Inc：企業の製品パイプライン分析2018
    Summary DePuy Synthes Inc (DePuy Synthes), a subsidiary of Johnson & Johnson, is a medical device company that provides products for orthopedic and neurological procedures. DePuy Synthes operates through eight divisions: joint reconstruction, sports medicine, neurological, spine, trauma, cranio-maxi …
  • Molecular Templates Inc：企業のM&A・事業提携・投資動向
    Molecular Templates Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Molecular Templates Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Natural Alternatives International Inc (NAII)：企業の財務・戦略的SWOT分析
    Summary Natural Alternatives International Inc (NAI) is a formulator and manufacturer of customized nutritional supplements. It manufactures and distributes the only patented beta-alanine supplement CarnoSyn. It offers services such as science-based product formulation, raw material acquisition and …
  • Samsung Securities Co., Ltd. (016360)：企業の財務・戦略的SWOT分析
    Samsung Securities Co., Ltd. (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Commercial Bank of Dubai PSC：企業の戦略・SWOT・財務情報
    Commercial Bank of Dubai PSC - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank of Dubai PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • FHI 360：企業の戦略的SWOT分析
    FHI 360 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Hubbell Incorporated：企業の戦略・SWOT・財務情報
    Hubbell Incorporated - Strategy, SWOT and Corporate Finance Report Summary Hubbell Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆